MICHELLE SURRETT: Open Payments
NPI 1114110665 · CAYCE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$796 in 38 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $716 · 2025 $796
Food & beverage: $796
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $245 |
| Corcept Therapeutics | 4 | $151 |
| Dynavax Technologies Corporation | 2 | $51 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| Stryker Corporation | 1 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Sumitomo Pharma America, Inc. | 1 | $33 |
| SANOFI-AVENTIS U.S. LLC | 1 | $30 |
| Edwards Lifesciences Corporation | 1 | $29 |
| Novo Nordisk Inc | 1 | $21 |
Products named: Korlym, VRAYLAR, QULIPTA, UBRELVY, Heplisav-B, REXULTI, FLOWTRIEVER CATHETER, S, GEMTESA.
Industry payments across SC — which companies pay providers there.
